1Purysko AS, Remer EM, Veniero JC. Focal liver lesion detection and characterization with Gd-EOB-DTPA [J].Clin Radiol,2011,66(7) :673-684.
2Schuhmann-Giampieri G,Schmitt-Willich H, Press WR, et al. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatohiliary system[J]. Radiology, 1992, 183(1) :59-64.
3H amm B,Staks T, Mi:hler A, et al. Phase I clinical evaluation o{ Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetis, and MR imaging[J]. Radiology, 1995, 195(3) :785-792.
4Tanimoto A,Lee JM, Murakami T, et al. Consensus report of the 2nd International Forum for Liver MRI[J]. Eur Radiol, 2009,19(Suppl 5) :975-989.
5Ringe KI, Husarik DB, Sirlin CB, et al. Gadoxetate disodium- enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver[J]. AJR Am J Roentgenol, 2010,195 (1) : 13-28.
6Kudo M. Will Gd-EOB-MRI change the diagnostic algorithm in hepatocellular carcinoma [J]. Oncology,2010,78(Suppl 1) :87- 93.
7Motosugi U, lchikawa T, Tominaga L, et al. Delay before the hepatocyte phase of Gd EOB-DTPA-enhanced MR imaging: is it possible to shorten the examination time [J]. Eur Radiol, 2009,19 (11) : 2623-2629.
8Huppertz A, Haraida S, Kraus liver lesions at gadoxetic A, et al, Enhancement of focal acid-enhanced MR imaging: Correlation with histopathologic findings and spiral CT--initial observations[J]. Radiology,2005,234(2) :468-478. Z.
9eeh CJ, Grazioli L, Breuer J, et al. Diagnostic performance and description of morphological features of focal nodular hyperplasia in GD-EOB-DTPA-enhanced liver magneticresonance imaging: results o{ a multicenter trial [J].Invest Radio[, :008,43 (7) =504-511.
10Ahh SS,Kim M J, Lim JS, et al. Added value of gadoxetic acid- enhanced hepatohiliary phase MR imaging in the diagnosis of hepatocellular carcinoma [J]. Radiology, 2010, 255 (2) : 459- 466.
2Seale MK,Catalano OA,Saini S,et al. Hepatobiliary-specific MR con- trast agents: role in imaging the liver and biliary tree[J]. Radiographics, 2009,29(6) : 1725-1748.
3Lee NK,Kim S,Lee JW,et al. Biliary MR imaging with Gd-EOB-DTP and its clinical applications[J]. Radiographics, 2009,29 (6) : 1707-1724.
4Vogl TJ,Kuemmel S,Hammerstingl R,et al. Liver tumor:comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA[J]. Radiology, 1996, 200(1 ) :59-67.
5Zech CJ,Grazioli L, Jonas E,et al. Health-economic evaluation of three imaging strategies in patients with suspected colorectal liver metastases: Gd-EOB-DTPA-enhanced MRI vs. extracellular contrast media-en- hanced MRI and 3-phase MDCT in Germany,Italy and Sweden[J]. Eur Radiol, 2009,19 (3) : 753-763.
6Motosugi U,Ichikawa T,Morisaka H,et al. Detection of pancreatic car- cinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT[J]. Radiology, 2011,260 ( 2 ) : 446-453.
